MAPK8 and neoplasm: This finding may lend support to the idea that there existed delayed contributing tumor-initiating cells (which are also bona fide CSCs/CSLCs) in the primary tumors, the self-renewal capacity of which was limited (turned into tumor transient amplifying cells) by JNK inhibition.